Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

EMCURE PHARMACEUTICALS LTD.

NSE : EMCUREBSE : 544210ISIN CODE : INE168P01015Industry : Pharmaceuticals & DrugsHouse : Private

BSE1653.6059.75 (+3.75 %)

PREV CLOSE ( ) 1593.85

OPEN PRICE ( ) 1585.20

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 69170

TODAY'S LOW / HIGH ( )1574.70 1672.65

52 WK LOW / HIGH ( )890 1672.65

NSE1652.7059.3 (+3.72 %)

PREV CLOSE( ) 1593.40

OPEN PRICE ( ) 1593.40

BID PRICE (QTY) 1652.70 (39)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 946487

TODAY'S LOW / HIGH( ) 1576.30 1671.80

52 WK LOW / HIGH ( )889 1671.8

Quarters

Select year

( in Million)

Particulars

Dec 2025

Sep 2025

Jun 2025

Mar 2025

Audited / UnAudited

UnAudited

Net Sales

23634.78

22698.22

21005.37

21162.45

Total Expenditure

18707.34

18306.97

16837.64

17138.45

PBIDT (Excl OI)

4927.44

4391.25

4167.73

4024

Other Income

18.53

394.77

36.96

44.53

Operating Profit

4945.97

4786.02

4204.69

4068.53

Interest

379.75

325.42

267.55

390.25

Exceptional Items

-381.5

-35

-103.78

PBDT

4184.72

4460.6

3902.14

3574.5

Depreciation

1046.8

1046.43

994.56

968.37

Profit Before Tax

3137.92

3414.17

2907.58

2606.13

Tax

824.22

900.47

759.65

633.76

Provisions and contingencies

Profit After Tax

2313.7

2513.7

2147.93

1972.37

Extraordinary Items

Prior Period Expenses

Other Adjustments

Net Profit

2313.7

2513.7

2147.93

1972.37

Minority Interest

-8.29

-79.06

-78.4

-82.8

Shares of Associates

Other related items

Misc. Expenses Written off

Consolidated Net Profit

2305.41

2434.64

2069.53

1889.57

Equity Capital

1895.73

1895.65

1895.08

1894.83

Face Value (IN RS)

Reserves

Calculated EPS

12.16

12.84

10.92

9.97

Calculated EPS (Annualised)

48.64

51.37

43.68

39.88

No of Public Share Holdings

41944347

41923389

41859065

41834065

% of Public Share Holdings

22.13

22.12

22.09

22.08

PBIDTM% (Excl OI)

20.84

19.34

19.84

19.01

PBIDTM%

20.92

21.08

20.01

19.22

PBDTM%

17.70

19.65

18.57

16.89

PBTM%

13.27

15.04

13.84

12.31

PATM%

9.78

11.07

10.22

9.32

Notes

Risk Disclosures on Derivatives

Quarterly Results

EMCURE PHARMACEUTICALS LTD.